A detailed history of Brighton Jones LLC transactions in Cerus Corp stock. As of the latest transaction made, Brighton Jones LLC holds 18,705 shares of CERS stock, worth $30,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,705
Previous 14,009 33.52%
Holding current value
$30,302
Previous $19,000 52.63%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$1.16 - $1.6 $5,447 - $7,513
4,696 Added 33.52%
18,705 $29,000
Q2 2025

Jul 31, 2025

BUY
$1.22 - $1.51 $17,090 - $21,153
14,009 New
14,009 $19,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.